Gary Schwarz
Oral and Maxillofacial Surgery · McAllen, TXNPI 1861550469
Payments from drug & device makers
Across 54 payments — averaging $115.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Nobel Biocare USA$4K
- Henry Schein, Inc.$564
- Dentsply Sirona Inc$500
- Planmeca USA, Inc.$400
- Ultradent Products Inc$277
- Straumann USA LLC$185
- plus $460 from 7 others
What the payments were for
- Consulting fees$2,00032%
- Speaking & faculty fees$2,40039%
- Food & beverage$1,39823%
- Gifts$4127%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Nobel Biocare USA | 12 | $3,824 |
| Henry Schein, Inc. | 3 | $564 |
| Dentsply Sirona Inc | 20 | $500 |
| Planmeca USA, Inc. | 1 | $400 |
| Ultradent Products Inc | 3 | $277 |
| Straumann USA LLC | 4 | $185 |
| Kerr Corporation | 1 | $159 |
| Biohorizons Implant Systems Inc. | 2 | $155 |
| Geistlich Pharma, North America, Inc. | 3 | $50 |
| Zimvie Inc. | 2 | $40 |
| Pacira Pharmaceuticals Incorporated | 1 | $22 |
| Medtronic | 1 | $18 |
| Zimmer Biomet | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EDUCATION$2,000
- NOBELPARALLEL$1,610
- NOBELACTIVE$1,610
- PLANMECA PROMAX$400
- ZIRCONIA ABUTMENT PREPARATION KIT$159
- Opalescence$136
How this compares
$6,210 in reported general payments places this provider in the 85th percentile of 591 oral and maxillofacial surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ibuprofen | 445 | $1,106 |
| Amoxicillin | 433 | $1,039 |
| Clarithromycin | 14 | $715 |
| Methylprednisolone | 77 | $444 |
| Pentoxifylline | 13 | $339 |
| Clindamycin Hcl | 30 | $229 |
| Azithromycin | 62 | $218 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 20 | $157 |
| Chlorhexidine Gluconate | 12 | $51 |
Paid to pharmacies, not to this prescriber.
Other oral and maxillofacial surgery in McAllen
- James MelvilleHouston$242K
- Arthur FieldsPlano$237K
- Donald GardnerHouston$234K
- Pedro FrancoIrving$91K
- Fayette WilliamsFort Worth$74K
- Craig BuchmannKeller$69K
- John ZunigaDallas$61K
- David AlfiHouston$58K
- Arshad KaleemEl Paso$42K
- Timothy WoernleyHouston$41K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.